Profile picture

Associate Professor Gorav Batra

Uppsala University, Uppsala (Sweden)
Membership: FESC Member
Follow
Biography
Gorav Batra is an Associate Professor of Cardiology at Uppsala University and Uppsala Clinical Research Center, as well as a Consultant Cardiologist at Uppsala University Hospital, Sweden. He is a Fellow of the ESC. Gorav Batra has served as a primary investigator for several international clinical trials in cardiology. He is a member of the steering committee of the RIKS-HIA (SWEDEHEART) registry and a member of the EuroHeart Data Science Group.
Logo ESC

Contributor content

N-terminal prohormone of brain natriuretic peptide predicts recurrent cardiovascular events in patients with acute coronary syndrome both in the acute and post-discharge setting: a TRACER substudy
Presentation
N-terminal prohormone of brain natriuretic peptide predicts recurrent cardiovascular events in patients with acute coronary syndrome both in the acute and post-discharge setting: a TRACER substudy
Dramatic improvements in survival in women and men with acute myocardial infarction over 30 years: a nationwide cohort study
Presentation
Dramatic improvements in survival in women and men with acute myocardial infarction over 30 years: a nationwide cohort study
National registry-based quality development and outcome improvement over 30 years
Presentation
National registry-based quality development and outcome improvement over 30 years
Pre- and postoperative atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome
Presentation
Pre- and postoperative atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are associated with improved outcome but do not prevent new-onset atrial fibrillation after acute myocardial infarction
Presentation
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are associated with improved outcome but do not prevent new-onset atrial fibrillation after acute myocardial infarction

ESC 365 is supported by